Record Quarterly Revenue
SANUWAVE reported Q3 2025 revenues of $11.4 million to $11.6 million, setting an all-time company record and reflecting a 12% to 14% sequential growth from Q2 and a 22% to 24% increase compared to the same quarter last year.
Significant System Sales
The company placed a record number of 155 systems in the quarter, indicating strong sales performance.
Positive Reimbursement Outlook
Proposed changes in reimbursement for UltraMIST suggest a small increase of $2 to $4, equating to roughly 50 to 100 basis points, which is viewed positively in the wound care context.
Strong September Performance
September was the best single month in company history for revenue, system sales, and applicators, marking a strong recovery after a slow start to the quarter.